ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 2456

$716K Total Retail Price of All Prescriptions

Rank: 98 out of 2456

755 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,775 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
OMEPRAZOLE 863 402 1 3
SIMVASTATIN 852 609 2 2
LISINOPRIL 806 495 3 1
AMLODIPINE BESYLATE 515 369 4 5
METOPROLOL TARTRATE 442 331 5 10
LEVOTHYROXINE SODIUM 441 292 6 4
METFORMIN HCL 439 229 7 11
HYDROCHLOROTHIAZIDE 416 291 8 7
PRAVASTATIN SODIUM 388 300 9 15
PROAIR HFA 302 125 10 22
FUROSEMIDE 290 202 11 8
OXYCODONE-ACETAMINOPHEN 233 89 S2 12 35
ATENOLOL 227 148 13 6
FLUTICASONE PROPIONATE 214 111 14 30
GABAPENTIN 201 91 15 16
ATORVASTATIN CALCIUM 193 136 16 12
WARFARIN SODIUM 186 136 17 9
LANTUS 168 112 18 44
SERTRALINE HCL 164 100 19 21
GLYBURIDE 164 97 R 19 40
TAMSULOSIN HCL 148 107 21 32
METOPROLOL SUCCINATE 142 100 22 13
NABUMETONE 142 27 22 164
ALENDRONATE SODIUM 137 108 24 19
OXYCODONE HCL 134 29 S2 25 38
LANTUS SOLOSTAR 117 36 26 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 48 27 41
PANTOPRAZOLE SODIUM 112 48 28 37
ZOLPIDEM TARTRATE 112 50 28 28
CRESTOR 112 66 28 25
TRAZODONE HCL 111 70 31 17
OXYCODONE HCL-ACETAMINOPHEN 110 16 S2 32 101
CYMBALTA 110 49 32 65
CYCLOBENZAPRINE HCL 109 40 R 34 77
FLUOXETINE HCL 109 72 34 45
DONEPEZIL HCL 105 96 36 23
CLOPIDOGREL 104 82 37 55
DIOVAN 102 65 38 26
ADVAIR DISKUS 101 54 39 36
ENALAPRIL MALEATE 95 56 40 70
INSULIN SYRINGE 95 56 40 72
FLOVENT HFA 91 41 42 104
PEN NEEDLE 85 31 43 150
GLIPIZIDE 80 56 44 46
ALLOPURINOL 78 65 45 27
TRAMADOL HCL 77 49 46 24
PLAVIX 76 62 47 79
HYDROCODONE-ACETAMINOPHEN 73 21 S3 48 20
MORPHINE SULFATE ER 72 24 S2 49 98
BUPROPION HCL SR 72 31 49 119
LOSARTAN POTASSIUM 68 43 51 18
BACLOFEN 65 17 52 112
VERAPAMIL ER 65 35 52 91
CITALOPRAM HBR 64 44 54 14
CARVEDILOL 63 43 55 54
PREDNISONE 63 38 55 39
NEXIUM 63 22 55 80
NAPROXEN 63 18 55 109
LOVASTATIN 63 58 55 34
MECLIZINE HCL 60 30 60 107
RANITIDINE HCL 57 40 61 31
POLYETHYLENE GLYCOL 3350 56 28 62 64
TERAZOSIN HCL 56 26 62 76
HUMALOG 55 27 64 123
QUETIAPINE FUMARATE 53 32 65 47
PAROXETINE HCL 52 22 66 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.